跳至主要内容
临床试验/NCT06288035
NCT06288035招募中3 期

Oral Dexamethasone at Night to Prevent Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Protocol for Randomized Clinical Trial

Mansoura University1 个研究点 分布在 1 个国家目标入组 814 人开始时间: 2024年3月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
招募中
入组人数
814
试验地点
1
主要终点
Postoperative nausea or vomiting (PONV)

研究概览

简要总结

Postoperative nausea and vomiting (PONV) are common complications after laparoscopic cholecystectomy. This study aims to evaluate the efficacy of the administration of prophylactic oral dexamethasone at night before surgery in preventing PONV after elective laparoscopic cholecystectomy.

详细描述

Background:

Postoperative nausea and vomiting (PONV) are common complications after laparoscopic cholecystectomy. This study aims to evaluate the efficacy of the administration of prophylactic oral dexamethasone 12 hours before induction of anesthesia in preventing PONV after elective laparoscopic cholecystectomy, as it reaches its peak effect at 2-12 hours and lasts for 72 hours after oral administration.

Methods:

This is a parallel, two-arm, randomized (1:1), controlled, single-center non-inferiority trial. Adults (≥18 years) with ASA physical status I-III scheduled for elective laparoscopic cholecystectomy will be eligible for inclusion. The participants will be randomized to receive either 8 mg of IV Dexamethasone at the time of induction of anesthesia or 8 mg of oral Dexamethasone 12 hours before induction of anesthesia. The primary outcome will be the incidence of postoperative nausea and vomiting. A total of 814 patients are intended to be recruited for this non-inferiority trial.

Discussion:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

盲法说明

The outcome assessors will be blinded to the group allocation.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all consecutive adults (older than 18 years) with ASA physical status I-III undergoing elective laparoscopic cholecystectomy surgery.

排除标准

  • steroids or antiemetics within 1 week of surgery
  • chronic opioid therapy
  • history of allergy to any of the study drug
  • serum creatinine > 1.4 mg/dl
  • liver enzymes > triple the normal limits
  • pregnancy
  • patient refusal
  • and psychiatric or neurologic diseases or socioeconomic status that would hinder the postoperative quality of recovery questionnaire
  • laparoscopic surgery is converted to open surgery after enrollment

研究组 & 干预措施

At-night oral dexamethasone

Experimental

Patients in the intervention group will receive oral 8 mg dexamethasone at night before surgery. The time of dexamethasone administration will be recorded.

干预措施: Dexamethasone Oral (Drug)

At-induction dexamethasone

Active Comparator

Patients in the control group will receive intravenous 8 mg dexamethasone just before or at the induction of anesthesia. The dexamethasone ampule will be diluted in a 10 ml syringe and given in at least one minute to avoid unpleasant sensations in injection.

干预措施: Dexamethasone (Drug)

结局指标

主要结局

Postoperative nausea or vomiting (PONV)

时间窗: 24 hours after surgery

incidecne of PONV

次要结局

  • Rescue antiemetic(24 hours after surgery)
  • Early PONV(within 6 hours after surgery)
  • Visual Analogue Scale (VAS) at the time of discharge from PACU(within 2 hours at the time of discharge from PACU)
  • Post-Discharge Nausea and Vomiting (PDNV)(72 hours after surgery.)
  • Late PONV(6 - 24 hours after surgery)
  • Postoperative fatigue(after 24 hours at the time of discharge from the hospital)
  • Postoperative quality of recovery(after 24 hours at the time of discharge from the hospital)
  • VAS at the time of discharge from hospital(after 24 hours at the time of discharge from the hospital)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Oral Dexamethasone for Postoperative Nausea and... | 临床试验